Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL304882

CCCC[N+](CCCC)(CCCC)CCCC.O=S(=O)([O-])C(F)(F)C(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 3/20 0.41
SLC22A2 O15244 1/20 0.37
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
MMP1 P03956 2/20 0.36
MMP2 P08253 2/20 0.36
MMP9 P14780 2/20 0.36
MMP8 P22894 2/20 0.36
MMP13 P45452 2/20 0.36
ALDH1A1 P00352 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
ALOX12 P18054 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HIF1A Q16665 1/20 0.34
HSD17B10 Q99714 1/20 0.34
KCNH2 Q12809 6/20 0.34
CES1 P23141 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL305806 0.98 SLC22A1 (0.40) SLC22A1SLC22A2CA1CA2MMP1
Tetrapentylammonium SCHEMBL28784950 0.97 SLC22A1 (0.41) SLC22A1SLC22A2CA1CA2MMP1
Tetrapentylammonium SCHEMBL30114905 0.95 SLC22A1 (0.40) SLC22A1SLC22A2CA1CA2MMP1
Tetrahexylammonium SCHEMBL29701291 0.95 SLC22A1 (0.43) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrahexylammonium SCHEMBL28483691 0.93 SLC22A1 (0.42) SLC22A1SLC22A2CA1CA2MMP1
SCHEMBL11754915 0.92 SLC22A1 (0.38) SLC22A1SLC22A2CA1CA2MMP1
SCHEMBL11759495 0.92 SLC22A1 (0.38) SLC22A1SLC22A2CA1CA2MMP1
SCHEMBL11757942 0.92 CA2 (0.36) SLC22A1CA1CA2MMP1MMP2
Tetrapropylammonium SCHEMBL237986 0.89 CA2 (0.38) SLC22A1CA1CA2MMP1MMP2
Tributylmethylammonium SCHEMBL4441609 0.88 CA2 (0.35) CA1CA2MMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 299 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12638775-B2 Methods and compositions for improved patterning of photoresist TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) 2026-05-26 US claimed
CN-117985945-A Photovoltaic glass self-cleaning nano coating and processing method thereof 捷科冉(厦门)新材料有限公司 2024-05-07 CN claimed
US-11567385-B2 Electrochromic device THE BOEING COMPANY (US) 2023-01-31 US claimed
EP-3753973-B1 A METHOD FOR SEALING A GAP BETWEEN ADJOINING OR CONNECTED SOLID SURFACES ON AN AIRCRAFT BOEING CO (US) 2022-09-28 EP claimed
US-20220171247-A1 ELECTROCHROMIC DEVICE THE BOEING COMPANY 2022-06-02 US claimed
CN-109280186-B Method and composition for curing the surface of uncured polysulfide rubber 波音公司 2022-05-10 CN claimed
US-11307476-B2 Electrochromic device THE BOEING COMPANY (US) 2022-04-19 US claimed
US-11292853-B2 Methods and compositions for curing a surface of an uncured polysulfide rubber THE BOEING COMPANY (US) 2022-04-05 US claimed
EP-3753973-A1 A METHOD FOR SEALING A GAP BETWEEN ADJOINING OR CONNECTED SOLID SURFACES ON AN AIRCRAFT The Boeing Company (US) 2020-12-23 EP claimed
EP-3431528-B1 METHODS AND COMPOSITIONS FOR CURING A SURFACE OF AN UNCURED POLYSULFIDE RUBBER BOEING CO (US) 2020-09-02 EP claimed
US-20190023814-A1 METHODS AND COMPOSITIONS FOR CURING A SURFACE OF AN UNCURED POLYSULFIDE RUBBER THE BOEING COMPANY 2019-01-24 US claimed
EP-3431528-A1 METHODS AND COMPOSITIONS FOR CURING A SURFACE OF AN UNCURED POLYSULFIDE RUBBER The Boeing Company (US) 2019-01-23 EP claimed
CN-104143494-B There is the plasma processing chamber component that protective layer is formed in situ in plasma exposure face 朗姆研究公司 2018-08-14 CN claimed
US-20160365228-A1 COMPONENT OF A PLASMA PROCESSING APPARATUS HAVING A PROTECTIVE IN SITU FORMED LAYER ON A PLASMA EXPOSED SURFACE LAM RESEARCH CORPORATION 2016-12-15 US claimed
US-9449797-B2 Component of a plasma processing apparatus having a protective in situ formed layer on a plasma exposed surface LAM RESEARCH CORPORATION (US) 2016-09-20 US claimed
US-20140335698-A1 COMPONENT OF A PLASMA PROCESSING APPARATUS HAVING A PROTECTIVE IN SITU FORMED LAYER ON A PLASMA EXPOSED SURFACE LAM RESEARCH CORPORATION (US) 2014-11-13 US claimed
CN-104143494-A Component of a plasma processing apparatus having a protective in situ formed layer on a plasma exposed surface LAM RES CORP 2014-11-12 CN claimed
US-8217100-B2 Adhesive composition and optical member CHEIL INDUSTRIES, INC. (KR) 2012-07-10 US claimed
US-20100151298-A1 PROTON CONDUCTOR FOR FUEL CELL, ELECTRODE FOR FUEL CELL INCLUDING THE PROTON CONDUCTOR, AND FUEL CELL INCLUDING THE ELECTRODE SAMSUNG ELECTRONICS CO., LTD. (KR) 2010-06-17 US claimed
US-20090014123-A1 Adhesive composition and optical member Wuxi Hengxin Optoelectronic Materials Co., Ltd. (CN) 2009-01-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12638775-B2 Methods and compositions for improved patterning of photoresist DSG1, SCO2, ERCC1 SLC22A1 4731/4885SLC22A2 4572/4885CA1 57/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.